Internal Medicine, Rheumatology · Stockton, CA
NPI
1346400546
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5049 Pine Lake Ct
Stockton, CA, 95219
Phone (215) 279-0964
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.3M
1,824 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Swetha Ramachandran prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 310 prescriptions and refills. In total Swetha Ramachandran wrote 1,824 Medicare prescriptions that cost $1.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 310 | 851 | 126 | $6,266 |
| Prednisone Generic | 257 | 476 | 128 | $2,596 |
| Leflunomide Generic | 200 | 636 | 93 | $6,121 |
| Alendronate Sodium Generic | 158 | 434 | 64 | $1,561 |
| Hydroxychloroquine Sulfate Generic | 120 | 370 | 47 | $3,696 |
| Rasuvo Methotrexate/Pf | 76 | 184 | 21 | $78K |
| Enbrel Sureclick Etanercept | 60 | 60 | Under 11 | $301K |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 59 | 106 | 20 | $105K |
| Sulfasalazine Generic | 53 | 133 | 27 | $3,062 |
| Azathioprine Generic | 51 | 143 | 21 | $1,692 |
| Colchicine Generic | 43 | 117 | 19 | $1,410 |
| Allopurinol Generic | 41 | 132 | 17 | $461 |
| Xeljanz Tofacitinib Citrate | 40 | 40 | Under 11 | $107K |
| Mycophenolate Mofetil Generic | 37 | 98 | 19 | $5,157 |
| Enbrel Etanercept | 34 | 34 | Under 11 | $166K |
Brand drugs: 453 claims; generic drugs: 1,360 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Swetha Ramachandran were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.